BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 19552510)

  • 1. Bradykinin receptor antagonists--a review of the patent literature 2005-2008.
    Fincham CI; Bressan A; Paris M; Rossi C; Fattori D
    Expert Opin Ther Pat; 2009 Jul; 19(7):919-41. PubMed ID: 19552510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aryl sulfones as novel bradykinin B1 receptor antagonists for treatment of chronic pain.
    Biswas K; Aya T; Qian W; Peterkin TA; Chen JJ; Human J; Hungate RW; Kumar G; Arik L; Lester-Zeiner D; Biddlecome G; Manning BH; Sun H; Dong H; Huang M; Loeloff R; Johnson EJ; Askew BC
    Bioorg Med Chem Lett; 2008 Sep; 18(17):4764-9. PubMed ID: 18706809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual antagonists of the bradykinin B1 and B2 receptors based on a postulated common pharmacophore from existing non-peptide antagonists.
    Morissette G; Bouthillier J; Marceau F
    Biol Chem; 2006 Feb; 387(2):189-94. PubMed ID: 16497151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peptide and non-peptide bradykinin receptor antagonists: role in allergic airway disease.
    Abraham WM; Scuri M; Farmer SG
    Eur J Pharmacol; 2006 Mar; 533(1-3):215-21. PubMed ID: 16455073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel pharmacotherapy of acute hereditary angioedema with bradykinin B2-receptor antagonist icatibant.
    Bas M; Bier H; Greve J; Kojda G; Hoffmann TK
    Allergy; 2006 Dec; 61(12):1490-2. PubMed ID: 17073887
    [No Abstract]   [Full Text] [Related]  

  • 6. Bradykinin B1 receptor antagonists: a patent update 2009 - 2012.
    Bozó É; Éles J; Keserű GM
    Expert Opin Ther Pat; 2012 Dec; 22(12):1443-52. PubMed ID: 23033970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful long-term treatment with the bradykinin B2 receptor antagonist icatibant in a patient with hereditary angioedema.
    Greve J; Hoffmann TK; Schuler P; Lang S; Chaker A; Bas M
    Int J Dermatol; 2011 Oct; 50(10):1294-5. PubMed ID: 21950301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of idiopathic nonhistaminergic angioedema with bradykinin B2 receptor antagonist icatibant.
    Del Corso I; Puxeddu I; Sardano E; Geraci S; Breggia M; Rocchi V; Migliorini P
    Ann Allergy Asthma Immunol; 2012 Jun; 108(6):460-1. PubMed ID: 22626601
    [No Abstract]   [Full Text] [Related]  

  • 9. Cyclopropylamino acid amide as a pharmacophoric replacement for 2,3-diaminopyridine. Application to the design of novel bradykinin B1 receptor antagonists.
    Wood MR; Schirripa KM; Kim JJ; Wan BL; Murphy KL; Ransom RW; Chang RS; Tang C; Prueksaritanont T; Detwiler TJ; Hettrick LA; Landis ER; Leonard YM; Krueger JA; Lewis SD; Pettibone DJ; Freidinger RM; Bock MG
    J Med Chem; 2006 Feb; 49(4):1231-4. PubMed ID: 16480259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potent bradykinin B1 receptor antagonists: 4-substituted phenyl cyclohexanes.
    Su DS; Lim JL; Markowitz MK; Wan BL; Murphy KL; Reiss DR; Harrell CM; O'Malley SS; Ransom RW; Chang RS; Pettibone DJ; Tang C; Prueksaritanont T; Freidinger RM; Bock MG
    Bioorg Med Chem Lett; 2007 Jun; 17(11):3006-9. PubMed ID: 17428657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The bradykinin B2 receptor antagonist icatibant (Hoe 140) blocks aminopeptidase N at micromolar concentrations: off-target alterations of signaling mediated by the bradykinin B1 and angiotensin receptors.
    Bawolak MT; Fortin JP; Vogel LK; Adam A; Marceau F
    Eur J Pharmacol; 2006 Dec; 551(1-3):108-11. PubMed ID: 17026984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular B1 kinin receptors in patients with congestive heart failure.
    Lang NN; Cruden NL; Tse GH; Bloomfield P; Ludlam CA; Fox KA; Newby DE
    J Cardiovasc Pharmacol; 2008 Nov; 52(5):438-44. PubMed ID: 19033823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and functional pharmacology of the bradykinin B1 receptor in the normal and inflamed human gallbladder.
    Andre E; Gazzieri D; Bardella E; Ferreira J; Mori MA; Saul VV; Bader M; Calixto JB; De Giorgio R; Corinaldesi R; Geppetti P; Trevisani M
    Gut; 2008 May; 57(5):628-33. PubMed ID: 18182589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aspirin inhibits human bradykinin B2 receptor ligand binding function.
    Gardes J; Michineau S; Pizard A; Alhenc-Gelas F; Rajerison RM
    Biochem Pharmacol; 2008 May; 75(9):1807-16. PubMed ID: 18355801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Intra-articular 4-(S)-amino-5-(4-{4-[2,4-dichloro-3-(2,4-dimethyl-8-quinolyloxymethyl)phenylsulfonamido]-tetrahydro-2H-4-pyranylcarbonyl} piperazino)-5-oxopentyl](trimethyl)ammonium chloride hydrochloride (MEN16132), a kinin B2 receptor antagonist, on nociceptive response in monosodium iodoacetate-induced experimental osteoarthritis in rats.
    Cialdai C; Giuliani S; Valenti C; Tramontana M; Maggi CA
    J Pharmacol Exp Ther; 2009 Dec; 331(3):1025-32. PubMed ID: 19745108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2,3-diaminopyridine bradykinin B1 receptor antagonists.
    Kuduk SD; Ng C; Feng DM; Wai JM; Chang RS; Harrell CM; Murphy KL; Ransom RW; Reiss D; Ivarsson M; Mason G; Boyce S; Tang C; Prueksaritanont T; Freidinger RM; Pettibone DJ; Bock MG
    J Med Chem; 2004 Dec; 47(26):6439-42. PubMed ID: 15588075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A fluorescent version of the bradykinin B2 receptor antagonist B-9430: pharmacological characterization and use in live cell imaging.
    Bawolak MT; Gera L; Bouthillier J; Stewart JM; Adam A; Marceau F
    Peptides; 2008 Sep; 29(9):1626-30. PubMed ID: 18565624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new class of bradykinin 1 receptor antagonists containing the piperidine acetic acid tetralin core.
    Fotsch C; Biddlecome G; Biswas K; Chen JJ; D'Amico DC; Groneberg RD; Han NB; Hsieh FY; Kamassah A; Kumar G; Lester-Zeiner D; Liu Q; Mareska DA; Riahi BB; Wang YJ; Yang K; Zhan J; Zhu J; Johnson E; Ng G; Askew BC
    Bioorg Med Chem Lett; 2006 Apr; 16(8):2071-5. PubMed ID: 16464576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful treatment of hereditary angioedema with bradykinin B2-receptor antagonist icatibant.
    Krause K; Metz M; Zuberbier T; Maurer M; Magerl M
    J Dtsch Dermatol Ges; 2010 Apr; 8(4):272-4. PubMed ID: 19758369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bradykinin antagonists modified with dipeptide mimetic beta-turn inducers.
    Alcaro MC; Vinci V; D'Ursi AM; Scrima M; Chelli M; Giuliani S; Meini S; Di Giacomo M; Colombo L; Papini AM
    Bioorg Med Chem Lett; 2006 May; 16(9):2387-90. PubMed ID: 16504505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.